- Home
- XBIO vs ISPC Comparison
XBIO vs ISPC Comparison
Compare XBIO & ISPC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XBIO
- ISPC
- Stock Information
- Founded
- XBIO N/A
- ISPC 2009
- Country
- XBIO United States
- ISPC United States
- Employees
- XBIO N/A
- ISPC N/A
- Industry
- XBIO Biotechnology: Pharmaceutical Preparations
- ISPC Precision Instruments
- Sector
- XBIO Health Care
- ISPC Health Care
- Exchange
- XBIO Nasdaq
- ISPC Nasdaq
- Market Cap
- XBIO 4.4M
- ISPC 4.6M
- IPO Year
- XBIO N/A
- ISPC 2021
- Fundamental
- Price
- XBIO $2.99
- ISPC $0.85
- Analyst Decision
- XBIO Hold
- ISPC
- Analyst Count
- XBIO 1
- ISPC 0
- Target Price
- XBIO N/A
- ISPC N/A
- AVG Volume (30 Days)
- XBIO 13.0K
- ISPC 8.5M
- Earning Date
- XBIO 08-13-2025
- ISPC 11-06-2025
- Dividend Yield
- XBIO N/A
- ISPC N/A
- EPS Growth
- XBIO N/A
- ISPC N/A
- EPS
- XBIO N/A
- ISPC N/A
- Revenue
- XBIO $2,446,221.00
- ISPC $5,908,088.00
- Revenue This Year
- XBIO $1.99
- ISPC $35.93
- Revenue Next Year
- XBIO $20.00
- ISPC N/A
- P/E Ratio
- XBIO N/A
- ISPC N/A
- Revenue Growth
- XBIO N/A
- ISPC N/A
- 52 Week Low
- XBIO $2.20
- ISPC $0.64
- 52 Week High
- XBIO $5.27
- ISPC $8.30
- Technical
- Relative Strength Index (RSI)
- XBIO 48.40
- ISPC 44.31
- Support Level
- XBIO $2.79
- ISPC $0.64
- Resistance Level
- XBIO $3.15
- ISPC $0.72
- Average True Range (ATR)
- XBIO 0.18
- ISPC 0.14
- MACD
- XBIO 0.04
- ISPC -0.02
- Stochastic Oscillator
- XBIO 59.50
- ISPC 24.84
About XBIO Xenetic Biosciences Inc.
Xenetic Biosciences Inc is a biopharmaceutical company focused on advancing innovative immuno-oncology technologies addressing difficult to treat cancers. The company's DNase technology is designed to improve outcomes of existing treatments, including immunotherapies, by targeting neutrophil extracellular traps (NETs), which are involved in the progression of many human cancers. Xenetic is also focused on advancing its systemic DNase program into the clinic as an adjunctive therapy for pancreatic carcinoma and other locally metastatic solid tumors.
About ISPC iSpecimen Inc.
iSpecimen Inc is a technology-driven company focused on connecting life science researchers who need human biofluids, solid tissues, and hematopoietic stem and immune cells for their research, with the available biospecimens. The company generates revenue by procuring various specimens from hospitals, laboratories, and other supply sites. Geographically, it has a presence in the Americas; Europe, the Middle East, Africa, and Asia Pacific, which majority, comes from the Americas.